FDA warns doctors of counterfeit Botox

December 24, 2012

Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.

The Food and Drug Administration said in a letter sent last month and released last week that batches of the wrinkle treatment shipped by suppliers owned by pharmacy Canada Drugs have not been approved by the FDA and that the agency cannot assure their effectiveness or their safety.

The FDA said Canada Drugs was previously tied to shipping unapproved and counterfeit cancer drugs.

The agency warns doctors about of buying drugs from sources other than licensed U.S. pharmacies. This is the fifth warning the agency has made this year about foreign suppliers providing unapproved drugs.

Explore further: FDA warning public of risks of online pharmacies

More information: 1.usa.gov/R7jKiR

shares

Related Stories

FDA warning public of risks of online pharmacies

September 28, 2012

The Food and Drug Administration is warning the public that most Internet pharmacies are fraudulent, selling drugs that likely are counterfeit and could harm or even kill people.

Recommended for you

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

kochevnik
1 / 5 (1) Dec 25, 2012
Standard corporfascism. FDA revolving door with big pharma

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.